Treatment of HCV has more than doubled since 2013, but we have a long way to go

July 28, 2016 - In 2015, close to 950,000 HCV patients were treated globally, more than double compared to 2013 (when an estimated 440,000 were treated). Of those treated in 2015, two-thirds were treated with the new DAAs while one third are still being treated with Interferon based therapies. Of all patients treated with the DAAs, 75% were in the US and Egypt and these two countries along with Spain, Pakistan, Germany and France accounted for 94% of all patients treated with the new therapies.

Although this data is encouraging, it will take close to 100 years to cure and treat everyone using current treatment and cure rates. An estimated 700,000 patients were cured in 2015 (using the average cure rate of the DAA and interferon based therapies) corresponding to less than one percent of all infected.


Polaris Observatory was developed by:  
Made possible through funding from:
John Martin Foundation

Copyright © All rights reserved